Home › Markets › Health Care › BAX

Baxter International Inc. (BAX)

BAX trades on NYSE in Health Care, Medical/Dental Instruments. Numbers below come from the Nasdaq screener and SEC filings, each with its source.

Price · October 14, 2026
$24.89
+0.44% on the day
Market cap
$12.9B
Large cap
Revenue · 2025
$11.2B
+5.7% on 2024
Net income · 2025
-$957.0M
-8.5% net margin

Price, change, market cap, sector and industry: Nasdaq stock screener, as of October 14, 2026. Revenue: SEC XBRL frames, calendar 2025.

Profile

FieldValue
TickerBAX on NYSE
SectorHealth Care
IndustryMedical/Dental Instruments
CountryUnited States
IPO yearNot reported by the screener
SEC CIK0000010456
SEC industry codeSurgical & Medical Instruments & Apparatus
Incorporated inDE

Financials · 2025

LineValue
Revenue$11.2B
Net income-$957.0M
Operating income-$308.0M
Net margin-8.5%
Operating margin-2.7%
Revenue growth+5.7%
Cash$2.0B
Total assets$20.1B
P/E (computed)Net income was not positive
P/S (computed)1.1×

Key SEC documents

DocumentFormFiled
Latest prospectus or offering document424B22025-11-20
Latest annual report10-K2026-02-12
Latest quarterly / interim10-Q2026-07-30
Latest current report8-K2026-08-19
Latest proxyDEFA14A2026-04-29

Source: SEC EDGAR submissions feed, 1,000 recent filings. All filings on EDGAR.

Price moves

WindowReturn
1 week+3.1%
1 month+4.3%
3 months+5.9%
Year to date+29.4%
1 year+11.8%
From 52-week high-12.8%

Source: Yahoo Finance daily closes, last bar 2026-10-14. Computed by Sophia Capital from daily closes; cap, sector and tier from the Nasdaq screener.

Peers in Medical/Dental Instruments

TickerCompanyPriceDayMarket cap
PENPenumbra Inc.$320.01-0.30%$12.6B
SOLVSolventum Corporation$86.30+1.16%$14.7B
GMEDGlobus Medical Inc.$76.32+0.10%$10.2B
GKOSGlaukos Corporation$165.50-1.50%$9.8B
PODDInsulet Corporation$138.13-1.20%$9.6B
WSTWest Pharmaceutical Services Inc.$371.82+1.15%$26.2B
HAEHaemonetics Corporation$121.72-0.28%$5.5B
TFXTeleflex Incorporated$124.44-1.00%$5.3B

The full dossier has every filing, three years of financials, private raises and the people who signed them.

Open the full dossier